Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study.

Pain·2026
Same author

Comparison of Quality of Life Between Patients with Chronic Unilateral Vestibular Hypofunction and Bilateral Vestibulopathy.

The journal of international advanced otology·2026
Same author

Effect of dual hepatic and portal vein embolization on future liver remnant function and volume prior to major hepatectomy.

Annals of hepato-biliary-pancreatic surgery·2026
Same author

Outcomes of Liver Transplant Versus Partial Hepatectomy for Perihilar Cholangiocarcinoma Patients Requiring Arterial Reconstruction.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study.

The British journal of surgery·2026
Same author

Outcomes of laser hemorrhoidoplasty in grade II-IV hemorrhoidal disease: a four-year, single center experience.

Revista espanola de enfermedades digestivas·2026
Same journal

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2025

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

137

Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial.

Robert S Fichtinger1,2, Luca A Aldrighetti3, Mohammed Abu Hilal4,5

  • 1Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|April 19, 2024
PubMed
Summary
This summary is machine-generated.

Laparoscopic major liver resection (hemihepatectomy) offers faster functional recovery and better quality of life compared to open surgery. This approach also speeds up adjuvant therapy for cancer patients without compromising outcomes.

More Related Videos

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

1.1K
Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver
12:27

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Published on: June 16, 2023

2.8K

Related Experiment Videos

Last Updated: Jun 28, 2025

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

137
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

1.1K
Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver
12:27

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Published on: June 16, 2023

2.8K

Area of Science:

  • Hepatobiliary Surgery
  • Minimally Invasive Surgery
  • Surgical Oncology

Background:

  • Major liver resections, including hemihepatectomy, are complex procedures for primary or metastatic liver cancer.
  • Traditional open surgery carries significant recovery times and potential impacts on quality of life.
  • Advancements in minimally invasive techniques, such as laparoscopy, offer potential benefits in surgical recovery and patient outcomes.

Purpose of the Study:

  • To compare functional recovery, morbidity, and quality of life (QoL) after laparoscopic versus open major liver resection (hemihepatectomy).
  • To evaluate oncologic outcomes, including resection margin status and time to adjuvant therapy, in patients with cancer undergoing hemihepatectomy.

Main Methods:

  • A multicenter, randomized controlled, patient-blinded, superiority trial involving adult patients undergoing hemihepatectomy.
  • Data collected from 16 European hospitals between November 2013 and December 2018.
  • Primary outcome: time to functional recovery; Secondary outcomes: morbidity, QoL, resection margins, time to adjuvant therapy.

Main Results:

  • Laparoscopic hemihepatectomy showed a significantly shorter median time to functional recovery (4 days vs. 5 days; P < .001).
  • No significant difference in major complication rates between laparoscopic and open approaches (14.5% vs. 16.9%; P = .58).
  • Laparoscopic surgery led to significantly higher QoL scores (global health status and body image) and a shorter time to adjuvant systemic therapy for cancer patients (P = .009).

Conclusions:

  • Laparoscopic hemihepatectomy provides a faster functional recovery compared to open surgery.
  • The laparoscopic approach is associated with improved quality of life and expedited adjuvant therapy for cancer patients.
  • Laparoscopic major liver resection is a safe and effective alternative to open surgery, with enhanced recovery and oncologic benefits.